Universal Health Services, Inc. (NYSE:UHS) Shares Sold by Nuance Investments LLC

Nuance Investments LLC lessened its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 82.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 252,628 shares of the health services provider's stock after selling 1,211,293 shares during the quarter. Nuance Investments LLC owned approximately 0.37% of Universal Health Services worth $38,511,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Invesco Ltd. grew its holdings in shares of Universal Health Services by 4.1% in the third quarter. Invesco Ltd. now owns 3,398,974 shares of the health services provider's stock valued at $427,353,000 after purchasing an additional 134,122 shares during the period. Massachusetts Financial Services Co. MA raised its position in shares of Universal Health Services by 48.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,967,220 shares of the health services provider's stock valued at $247,339,000 after buying an additional 638,166 shares during the period. American Century Companies Inc. lifted its holdings in Universal Health Services by 12.9% in the third quarter. American Century Companies Inc. now owns 1,707,708 shares of the health services provider's stock valued at $214,710,000 after acquiring an additional 195,650 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Universal Health Services by 3.5% during the third quarter. JPMorgan Chase & Co. now owns 1,090,010 shares of the health services provider's stock worth $137,047,000 after acquiring an additional 37,243 shares during the last quarter. Finally, Northern Trust Corp raised its position in Universal Health Services by 0.3% in the third quarter. Northern Trust Corp now owns 634,646 shares of the health services provider's stock valued at $79,794,000 after purchasing an additional 1,646 shares during the period. Hedge funds and other institutional investors own 86.05% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on UHS. TD Cowen boosted their price objective on shares of Universal Health Services from $181.00 to $183.00 and gave the company a "hold" rating in a report on Tuesday, April 30th. The Goldman Sachs Group upped their price target on Universal Health Services from $170.00 to $189.00 and gave the stock a "buy" rating in a research note on Monday, March 4th. Stephens reaffirmed an "equal weight" rating and issued a $185.00 price objective on shares of Universal Health Services in a research note on Thursday, April 25th. JPMorgan Chase & Co. increased their target price on Universal Health Services from $144.00 to $182.00 and gave the stock a "neutral" rating in a research note on Wednesday, March 13th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Universal Health Services from $208.00 to $203.00 and set a "buy" rating for the company in a research report on Friday, April 12th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Universal Health Services has an average rating of "Hold" and a consensus price target of $183.20.

Insiders Place Their Bets

In other news, CFO Steve Filton sold 35,000 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $176.82, for a total transaction of $6,188,700.00. Following the completion of the sale, the chief financial officer now owns 68,785 shares in the company, valued at $12,162,563.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 16.10% of the stock is owned by insiders.

Universal Health Services Stock Performance

Shares of NYSE UHS traded up $1.04 during trading hours on Friday, reaching $178.09. The stock had a trading volume of 573,418 shares, compared to its average volume of 809,175. The firm has a 50-day moving average of $171.90 and a 200-day moving average of $156.66. The firm has a market cap of $11.97 billion, a price-to-earnings ratio of 15.09, a PEG ratio of 0.89 and a beta of 1.26. The company has a current ratio of 1.38, a quick ratio of 1.28 and a debt-to-equity ratio of 0.75. Universal Health Services, Inc. has a fifty-two week low of $119.90 and a fifty-two week high of $183.61.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its earnings results on Wednesday, April 24th. The health services provider reported $3.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.14 by $0.56. The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.78 billion. Universal Health Services had a net margin of 5.57% and a return on equity of 13.34%. The company's revenue for the quarter was up 10.8% compared to the same quarter last year. During the same period last year, the firm posted $2.34 earnings per share. Equities research analysts predict that Universal Health Services, Inc. will post 13.58 earnings per share for the current year.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.